Clinical characteristics and fatal outcomes of hypertension in patients with severe COVID-19

Xiaocheng Cheng(The Affiliated Yongchuan Hospital of Chongqing Medical University), Dongying Zhang(Huaian First People’s Hospital), Guoqiang Cai(University of Alabama at Birmingham), Shu Qin(The Affiliated Yongchuan Hospital of Chongqing Medical University), Min Sun(The Affiliated Yongchuan Hospital of Chongqing Medical University), Lei Gao(Fujian Medical University), Dan Jiang(The Affiliated Yongchuan Hospital of Chongqing Medical University), Xuesong Wen(The Affiliated Yongchuan Hospital of Chongqing Medical University)
Aging
November 16, 2020
10.18632/aging.104019
Cited by 18

Related Papers

Prognostic value of NT-proBNP in patients with severe COVID-19
|Respiratory Research|2020|307
Therapeutic Targeting of Src Kinase in Myofibroblast Differentiation and Pulmonary Fibrosis
|Journal of Pharmacology and Experimental Therapeutics|2014|111
Trimetazidine protects against myocardial ischemia/reperfusion injury by inhibiting excessive autophagy
|Journal of Molecular Medicine|2018|106
TNAP inhibition attenuates cardiac fibrosis induced by myocardial infarction through deactivating TGF-β1/Smads and activating P53 signaling pathways
|Cell Death and Disease|2020|93
A single nucleotide polymorphism alters the sequence of SP1 binding site in the adiponectin promoter region and is associated with diabetic nephropathy among type 1 diabetic patients in the Genetics of Kidneys in Diabetes Study
|Journal of Diabetes and its Complications|2008|75